CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation

Positive
AI Analysis

Summary

Barclays initiated Ligand Pharmaceuticals with an Outperform rating, citing the company's biopharma royalty aggregation model.

Importance:3/10
Sentiment:
0.60
analyst_ratingoutperformroyalty_aggregation
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 25, 2026 6:19 PM

Read Original